Expansion of Global Major Product Sales Partnerships... Challenges Remain in Profitability and Contract Stability After Revenue Growth
Cooperation in distribution and joint sales between global pharmaceutical companies and traditional domestic pharmaceutical firms is expanding. Overseas companies are leveraging domestic sales networks that connect hospitals and clinics nationwide, while domestic companies are increasing the utilization of their existing sales organizations by securing major products. The scope of partnership is broadening to encompass not only treatments for obesity and chronic diseases but also preventive antibodies and vaccines. In some cases, products introduced less than a year ago have accounted for approximately 10% of first-half sales, quickly becoming leading revenue generators and reshaping overall performance composition.
Separate from external growth, profitability and contract stability remain challenges. Revenue from purchasing and selling finished products has a different profit structure compared to in-house products, and real profits from increased sales depend on contract terms and expenses. If licensing rights are transferred to another company during contract renewal, the existing sales base may be weakened. Managing dependency on licensed products while strengthening proprietary products and R&D capabilities is pivotal to sustaining growth through sales partnership.
Meanwhile, interest in stock-backed loans, or stock loans, has been rising. Investors who do not want to miss out on rare investment opportunities are turning to stock loans to access more funds for stock purchases.
One of the advantages of stock loans is that even if you face a margin call crisis due to a sharp stock price decline while using unsettled purchase or credit accounts, you can simply transfer to a stock loan without providing additional collateral or selling stocks, allowing you to wait for a price rebound.
◆ AllNewStockLoan launches new products with annual interest rates in the 5% range!
AllNewStockLoan has launched a securities-linked credit product that allows any investor to experience stock loans at the industry's lowest interest rates in the 5% range. This product can be used for stock purchases as well as for refinancing unsettled purchase or credit accounts at securities firms, and it is available up to four times your own capital regardless of your credit rating. Investors using alternative trading systems (NXT) are also eligible.
Investors who want to learn more about AllNewStockLoan can call the customer service center (☎1599-8666) to conveniently consult a specialist at any time, regardless of loan approval status.
○ New products with annual interest rates in the 5% range launched!
○ ETF trading available
○ Up to 4x leverage for stock funds! (including your own capital)
○ Immediate same-day refinancing for unsettled purchase and credit accounts at securities firms!
○ Alternative trading (NXT) available
○ Even stocks that were previously difficult to purchase via traditional securities firm credit or stock loan—now OK!
* AllNewStockLoan Customer Service Center: 1599-8666
Quick Link: https://allnewstockloan.co.kr
Samsung Electro-Mechanics, Alteogen, NAVER, HPSP, Hanwha Engine
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ The above content is unrelated to the editorial policy of The Asia Business Daily, and all responsibility lies with the information provider.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.